10/3/2022  3:30:11 PM Chg. - Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
14.7500USD - 273
Turnover: 1,475
-Bid Size: - -Ask Size: - 153 bill.USD - -

Business description

GSK is a british pharmaceutical and healthcare company. GSK manufactures drugs and vaccines for major disease areas such as asthma, cancer, infections, diabetes, digestive and mental health conditions. Many medicines were historically discovered or developed at GSK and its predecessor companies and are now sold as generics.

Management board & Supervisory board

Emma Walmsley
Management board
Iain Mackay, Brian McNamara, David Redfern, Deborah Waterhouse, Diana Conrad, Dr. Hal Barron (bis 1.08.2022), James Ford, Karenann Terrell, Luke Miels, Phil Thomson, Regis Simard, Roger Connor, Sally Jackson, Tony Wood (CSO ab 1.08.2022)
Supervisory board
Jonathan Symonds, Charles Bancroft, Dr Harry C. Dietz, Dr. Anne Beal, Dr. Hal Barron, Dr. Jesse Goodman, Dr. Laurie Glimcher, Dr. Vivienne Cox, Emma Walmsley, Iain Mackay, Lynn Elsenhans, Manvinder Singh Banga, Urs Rohner

Company data

Name: GlaxoSmithKline PLC
Address: 980 Great West Road,UK-Brentford, Middlesex TW8 9GS
Phone: +44-20-8047-5000
Fax: -
E-mail: -
Internet: www.gsk.com
Industry: Healthcare
Sector: Pharmaceutical Industry
Sub sector: Pharmaceuticals
End of financial year: 12/31
Free Float: 41.74%
IPO date: -

Investor relations

Name: Nick Stone
IR phone: -
IR Fax: -
IR e-mail: GSK.Investor-Relations@gsk.com

Company calendar

CW 45 | 11/2/2022 Interim Report 3rd Quarter/9 Months

Main Shareholders

BlackRock, Inc.
The Capital Group Companies, Inc.
Dodge & Cox